Dogwood Therapeutics DWTX
NASDAQ DWTX
$1.11 -0.06 (-5.13%)
As of: Oct 22, 2026 · 11:14 AM EDT

Dogwood Therapeutics (DWTX) Other Operating Expenses (2026)

Updated

Dogwood Therapeutics' Other Operating Expenses was $9.19 million in Q2 2026.

Analysis

Dogwood Therapeutics (DWTX) Other Operating Expenses (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,175.39 Bn 1,143.98 Bn 19.71 Bn
2 Johnson & Johnson 639.10 Bn 557.63 Bn 17.26 Bn
3 AbbVie 502.70 Bn 475.81 Bn 12.70 Bn
4 Merck 376.68 Bn 331.05 Bn 12.21 Bn
5 Novartis Ag 304.33 Bn 268.32 Bn 11.24 Bn
6 Astrazeneca 267.75 Bn 241.43 Bn 12.86 Bn
7 Amgen 242.34 Bn 197.73 Bn 7.24 Bn
8 Gilead Sciences 193.67 Bn 167.87 Bn 6.22 Bn
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn
10 Dogwood Therapeutics 37.88 Mn -1.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.19 Mn
API Access

Dogwood Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=DWTX&period=max&api_key=YOUR_API_KEY